Expert in Pharmaceutical and Biomedical Business Development, Technology Evaluation and Licensing
He has been intimately involved in the development, technical and market assessment, and licensing of wound care products including living skin equivalents, naturally derived growth factors, and hydrogels, as well as antimicrobial, ophthalmic, anti-inflammatory and allergy products.
Expert has extensive experience in the licensing, technology transfer, development, and technical evaluation of specialized drug delivery systems. Specialty areas include ophthalmic pharmaceuticals, subcutaneous implants, topical and transdermal delivery systems, new chemical entities for a variety of pharmaceutical applications, oral delivery of active agents which exhibit low water solubility and/or bioavailability, as well as oral delivery of proteins and peptides--a subject on which he organized and conducted a three-day international symposium. In addition, he has expertise in the field of auto-injection.
He has extensive experience with anti-microbial agents and disinfectants. An area of major work has been in the treatment of various polymeric medical and consumer devices to render their surfaces resistant to microbial attachment and proliferation. Other activities in this area have entailed out-licensing of antimicrobial technologies for use in ophthalmics, oral hygiene, veterinary, dermatology, dialysis, etc. plus formulations for state-of-the-art contact lens care products, oral care products, anti-infectives, and surface disinfectants.
He has been recognized as an expert in surface modification of biomaterials to enhance performance. The areas of activity include lubricity, reduced thrombogenicity, reduced inflammation and phlebitis, and enhanced resistance to infection.
Expert has been directly involved in the development, assessment, and licensing of ophthalmic pharmaceuticals and delivery methods as well as contact lens materials and contact lens care products.
Expert is knowledgeable of methods by which levels of allergens, metabolites, proteins, peptides, enzymes, and infectious agents can be measured in the human body. He can answer questions regarding the development, assessment, and regulatory registration and licensure aspects of medical diagnostics products.
He has worked with methods by which food products can be assessed for microbial contamination, presence of adulterants and contaminants (antibodies, hormones, steroids).
Expert was retained by an investment firm to evaluate the technical value of a "living skin equivalent" that was under development. After completing a technical and competitive analysis, he went on the become a consultant to the wound care company and, after six months in this capacity was asked to take on the role of president. He was involved in finance raising, business development and licensing. Although he has elected to remain in his consulting practice, expert is still in contact with the principals of the company. The company has since become a public corporation and, along with its marketing partners, introduced product to the market.
He has been retained by major multi-national pharmaceutical and medical device companies, e.g., Pfizer, CIBA Vision, as a member of product development teams. He is charged with coordinating the search for technologies that are suited to product improvement, line extension, etc.He has been retained by small and start-up companies - - frequently companies comprised of scientific founders - - to assist with strategic planning, preparation of business plans, and introduction to and negotiations with potential collaborators and licensees. He has been directly instrumental in the consummation of many licensing agreements.He has been retained by corporations and investment bankers in the conduct of due diligence in many of his areas of expertise.He has prepared individual and multi-client reports, as well as conducting multi-day symposia, in such areas as dermatology, ophthalmics, wound care, drug delivery, biomaterials, dental products, etc.He has represented the business interests of off-shore companies and institutions in the United States and has facilitated the successful out-licensing of their technologies in such diverse areas as drug delivery, wound care, antimicrobial and disinfecting technologies, surface treatments, diagnostics, etc.
Expert may consult nationally and internationally, and is also local to the following cities: New York, New York - Yonkers, New York - Newark, New Jersey - Jersey City, New Jersey - Paterson, New Jersey - Elizabeth, New Jersey - Bridgeport, Connecticut - Stamford, Connecticut - Philadelphia, Pennsylvania - Allentown, Pennsylvania
|Year: 1975||Degree: M.B.A.||Subject: Marketing||Institution: Fordham University|
|Year: 1970||Degree: Ph.D.||Subject: Physical Chemistry||Institution: Polytechnic Institute of Brooklyn|
|Year: 1963||Degree: B.S.||Subject: Chemistry||Institution: Queens College|
|Years: 1988 to Present||Employer: Undisclosed||Title: Founder and President||Department:||Responsibilities: Expert provides clientele (from start-ups to major pharmaceutical and medical device companies) with expertise in business development, technology and product in- or out-licensing and product development skills. His primary areas of focus are dermatology, urology, topical anesthetics, antimicrobial technologies, wound care, drug delivery and eye care products.|
|Years: 1987 to 1988||Employer: Alcide Corporation||Title: Vice President, Sales and Marketing||Department:||Responsibilities: He provided market, sales, and strategic planning for technologically advanced antimicrobial products, and technology licensing. Negotiated licences and increased gross revenues over 300%.|
|Years: 1982 to 1987||Employer: Bausch & Lomb, Inc.||Title: Director - Contact Lens and Eye Care Products||Department:||Responsibilities: Expert was involved in management of formulations research, engineering and process development, a pilot plant (a GMP facility), clinical research services, medical device development and project management; and in new technology evaluation, strategic planning, and in-license negotiating. Responsible for early ad mid-stage development and regulatory approval of the Re-Nu product line. Successfully negotiated contracts for state-of-the-art technologies.|
|Years: 1979 to 1982||Employer: Self||Title: Independent Consultant||Department:||Responsibilities: Expert provided clientele (start-ups to major pharmaceutical and medical device companies) with expertise in business development, technology and product in- or out-licensing and product development skills. His primary areas of focus were antimicrobial technologies, wound care, drug delivery, dental products (particularly dental implants) contact lenses, and eye care products.|
|Years: 1978 to 1979||Employer: NPD Dental Systems||Title: Vice President||Department:||Responsibilities: He was involved in a new division start-up; and in strategies for product introduction, staffing, marketing, and budgets. Achieved multi-million dollar sales in first year.|
|Years: 1975 to 1977||Employer: Hydro Med Sciences||Title: Product Manager||Department:||Responsibilities: He worked on strategic planning and implementation of sales and marketing strategy for the launch of a specialty wound care product (hydrogel).|
|Years: 1972 to 1975||Employer: Hydron Laboratories||Title: Technical Director||Department:||Responsibilities: Responsible for development and patent (sole patentee) of first successfully marketed hydrogel for topical treatment of severe burn wounds.|
|Years: 1970 to 1971||Employer: Johns Manville||Title: Senior Research Chemist||Department:||Responsibilities:|
|Years||Country / Region||Summary|
|Years: to Present||Country / Region: Australia||Summary: Represents the business interests in the United States of the Queensland Institute of Medical Research in the fields of Diagnostics and Pharmaceuticals.|
|Years: to Present||Country / Region: Israel||Summary: Represents, as a sub-contractor, the licensing interests of Yissum [the licensing arm of Hebrew University] and Hadasit [the licensing arm of Hadassah Hospital]; current interests include local anesthesia and wound care.|
|Years: 1999 to 2004||Country / Region: Spain||Summary: Represented the business interests of a firm involved in the development of novel antimicrobial compounds and disinfecting formulations.|
|Years: 1999 to 2003||Country / Region: United Kingdom||Summary: Represented Cortecs/Provalis in licensure of diagnostic products and drug delivery systems.|
|Years: 1995 to 2002||Country / Region: Japan||Summary: Worked with a major Japanese pharmaceutical company to introduce their technologies into the US - numerous licensing contracts were concluded.|
|Associations / Societies|
|Expert is a member of the American Chemical Society, the Controlled Release Society, the Licensing Executives Society, and the Society for Biomaterials (serving on the Program Committee and as reviewer for the Journal of Biomedical Materials Research).|
|Licenses / Certifications|
|Winner of multiple awards for scientific achievements, including Alumnus of the Year, Queens College|
|He was the Plenary Session Chairman for the Society for Biomaterials Annual Meeting.|
|Awards / Recognition|
|He was named one of the "100 Alumni Stars" of Queens College; recipient of R&D Magazine's R&D 100 awards; recipient of "Plastics - The Better Way" award.|
|Publications and Patents Summary|
|He has numerous publications, presentations and patents in wound care, drug delivery, contact lens and eye care, biomaterials, and antimicrobial technologies.|
|Expert Witness Experience|
|Expert has served as an expert witness giving depositions and testifying in court in cases covering such diverse disciplines as drug delivery and eye care.|
|Training / Seminars|
|He served as Vice President of Sales and Marketing at two companies. In this capacity, he devised launch programs for wound care, ophthalmic, oral hygiene and dental products, and veterinary products. Expert organized and conducted a 3-day symposium on the oral delivery of proteins and peptides.|
|He has experience locating vendors and providers of ophthalmic pharmaceuticals, diagnostics, drug delivery technologies, dermatologicals, allergy products,
fermentation/lyophilization contract manufacturers, hyaluronic acid-based technologies, auto-injectors, surface modification technologies, bioadhesives, and antimicrobial agents. He also has access to a computer database, and personal contacts for vendor locating.
|He served as Vice President of Sales and Marketing at two companies. In this capacity, he devised launch programs for wound care, ophthalmic, oral hygiene and dental products, and veterinary products.|
|Other Relevant Experience|
|Technology Management Network, LLC represents the technologies and business interests of British, Israeli, Spanish, Australian and Japanese firms.|